Blog

 

Abstract Image

 

There were two recent studies described below utilizing EagleBio’s Creatinine Microplate Assay, a kit designed for the quantitative determination of creatinine in urine by a microplate assay.This assay is part of our Oxidative Assay Kit Line which is a comprehensive group consisting of a numerous valuable products for assisting scientists in fields of research such as diabetes, cancer, aging, and other similar areas of study.

 

Publication:

Abundant rodent furan-derived urinary metabolites are associated with tobacco smoke exposure in humans

Authors: Alex E. Grill, Thaddeus Schmitt, Leah A. Gates, Ding Lu, Dipankar Bandyopadhyay, Jian-Min Yuan, Sharon E. Murphy, and Lisa A. Peterson

Study Summary:

Furan, a possible human carcinogen, is found in heat treated foods and tobacco smoke. Past studies have shown that humans are capable of converting furan to its reactive metabolite, cis-2-butene-1,4-dial (BDA), and thus may be susceptible to furan toxicity. Human risk assessment of furan exposure has been hindered because of the lack of mechanism-based exposure biomarkers.

In order to investigate this further, a study was performed at the University of Minnesota for evaluate six furan metabolites by measuring their levels in urine from furan-exposed rodents as well as in human urine from smokers and nonsmokers. The targets of this study were the metabolites that result from direct reaction of BDA with lysine (BDA-N(α)-acetyllysine) and from cysteine-BDA-lysine cross-links (N-acetylcyteine-BDA-lysine, N-acetylcysteine-BDA-Nα-acetyllysine and their sulfoxides. Researchers utilize Eagle Bioscience’s Creatinine Microplate Assay to measure creatinine in urine samples.

Five of the six metabolites were identified in urine from rodents treated with furan by gavage. BDA-N(α)-acetyllysine, N-acetylcysteine-BDA-lysine and its sulfoxide were detected in most human urine samples from three different groups. The levels of N-acetylcysteine-BDA-lysine sulfoxide were more than 10 times higher than the corresponding sulfide in many samples. The amount of this metabolite was higher in smokers relative to non-smokers and was significantly reduced following smoking cessation. Our results indicate a strong relationship between BDA-derived metabolites and smoking. Future studies will determine if levels of these biomarkers are associated with adverse health effects in humans.

 

Publication:

Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer

Authors: Sungshim L. Park,Steven G. Carmella, Menglan Chen, Yesha Patel, Daniel O. Stram, Christopher A. Haiman, Loic Le Marchand, Stephen S. Hecht

Study Summary:

Lung cancer is the leading cause of cancer death in the world and in order to have a better understanding of lung cancer susceptibility the different risks among smokers in varied ethnic groups needed to be evaluated. 

The results of the Multiethnic Cohort epidemiology study has clearly demonstrated that, compared to Whites and for the same number of cigarettes smoked, African Americans and Native Hawaiians have a higher risk for lung cancer whereas Latinos and Japanese Americans have a lower risk.  In addition, it was found that Acrolein and crotonaldehyde are two important constituents of cigarette smoke which have well documented toxic effects and could play a role in lung cancer etiology. 

Their urinary metabolites 3-hydroxypropylmercapturic acid (3-HPMA) and 3-hydroxy-1-methylpropylmercapturic acid (HMPMA), respectively, are validated biomarkers of acrolein and crotonaldehyde exposure.The levels of 3-HPMA and HMPMA were quanified in the urine of more than 2200 smokers from these five ethnic groups, and also carried out a genome wide association study using blood samples from these subjects. Creatinine levels were analyzed using Eagle Bioscience’s Creatinine Microplate Assay to measure creatinine in urine samples.

In conclusion, the overall results of this study suggest that acrolein and crotonaldehyde may be involved in lung cancer etiology, and that their divergent levels may partially explain the differing risks of Native Hawaiian and Latino smokers. No strong signals were associated with 3-HPMA in the genome wide association study, suggesting that formation of the glutathione conjugate of acrolein is mainly non-enzymatic, while the top significant association with HMPMA was located on chromosome 12 near the TBX3 gene, but its relationship to HMPMA excretion is not clear.

 

image above from Grill et. al  cited above

 

Related Kits:

Oxidative Stress Assays

SDMA (Symmetric Dimethylarginine) ELISA Assay Kit

Hydroxypyridinium Crosslinks HPLC Assay Kit

Related News:

EagleBio’s Creatinine Microplate Assay Kit Used in Studying High Incidence of Lung Cancer in Singapore Women

January 21, 2015- Eagle Biosciences Shares Some New Publications Across Multiple EagleBio Assay Kit Product Lines

New Antibody–Drug Conjugate (ADC) Study Utilizes Eagle Biosciences’ DM1 ADC ELISA Assay Kit

 

Antibody-drug conjugates (ADCs) are a new type of targeted therapy which are very promising in cancer treatment that significantly increase target specificity as well as reduce toxcity. ADCs are cell specific monoclonal antibodies that are conjugated with highly potent cyotoxics though a specific linker that help to deliver and release the drug inside the tumor cell. 

A recent study published in Molecular Cancer Therapeutics focused on evaluating the therapeutic potential of a new Antibody-drug conjugate (ADC), SYD985.  SYD985 is a HER2-targeting antibody–drug conjugate (ADC) based on trastuzumab and vc-seco-DUBA. The purpose of this research was to evaluate the therapeutic potential of
this new ADC f
or treatment of
patients with breast cancer.
This evauation was accomplished by comparing its preclinical antitumor
activity directly to that of T-DM1 in a series of high and low
HER2-expressing breast cancer PDX models. 

The promise of ADCs as a new class of drugs in
oncology is evident in the high number of ADCs that are currently in clinical development and even more that are in preclinical
programs and studies. Read More

 

Related Kits:

MMAE Antibody Drug Conjugate (ADC) ELISA Assay Kit

MMAF Antibody Drug Conjugate (ADC) ELISA Assay Kit

DM1 Antibody Drug Conjugate (ADC) ELISA Assay Kit

 

 

Phosphate Food Addivites: Reasons for Concern that they are Not on Food Labels

 

 

A study is in the works at Northwestern University focused on the additives in processed food, particularly phosphates and their impact on the heart. They have described phosphates as an additive that is so under the radar that it is actually not even listed on food labels. The American Heart Association (AHA) has teamed up with a new Northwestern Medicine research center to investigate the effects of these phosphate additives further in a population with higher rates of cardiovascular disease and who also consume more processed foods.

This research will be an extension of another Northwestern research already linking a high-phosphate diet to an increase of a hormone, fibroblast growth factor 23(FGF23), that strongl predicts risk of heart failure and death. Consumption of large amounts of phosphates causes the bones in your body to produce more FGF23 which thereby assists the body to excrete the excess phosphate through its action on the kidneys. If this process continues due to this poor diet rich in processed food, FGF23 may cause the walls of the heart’s main pumping chamber to thicken and stiffen which is called left ventricular hypertrophy. This creates a detrimental domino affect leading to heart failure. Read More

Related Kits:

FGF23 (C-Terminal) ELISA Assay Kit

FGF Basic (FGF-2) ELISA KIT

Bone Metabolism Assay Kits

Related News:

New Drug Target to Increase Bone Formation and Treat Multiple Diseases

EagleBio’s FGF23 (C-terminal) ELISA: Product Highlights

January 2015: Eagle Biosciences Introduces New FGF23(C-Terminal) ELISA Assay

 

Scientists at Imperial College London were performing a series of testing including sequencing the DNA of a morbidly obese young woman and some members of her family.This woman had an increased appetite which lead to major weight issues stemming from childhood. In addition, she had type 2 diabetes, learning difficulties, and reproductive problems. 

Based on the DNA sequencing, researchers found that this subject had inherited two copies of a harmful genetic change that meant she could not make a protein called carboxypeptidase-E (CPE). CPE is an enzyme responsible for the proper functioning of several hormones and brain transmitters controlling appetite, insulin, and other hormones important in the reproductive system. This clearly was a interesting finding that would explain the conditions and symptoms that the woman had been afflicted with her whole life.  

Previous studies have revealed that there are over 30 genes with harmful changes in DNA that cause extreme obesity.  Furthermore, there are several genes that when altered can cause type 2 diabetes as researchers have seen in this PLOS One study by NIHR Imperial Biomedical Research Centre and Diabetes UK. 

Genetic testing for obese individuals is important because it can provide patients with a diagnosis. It can also enable doctors to assist patients in providing genetic advice to family members as well as help them to obtain the best and most appropriate treatment.

In conclusion, diseases like this one are a recessive condition caused by inheriting an altered genetic sequence from both parents. This subject’s, parents were cousins so they most definitely had a higher chance to inherit the same genetic change from both parents. Read More

image above from www.sciencedaily.com

Related Kits:

Anti-ZnT8 (Zinc Transporter 8) ELISA

Insulin ELISA Assay Kit

ICA (Islet Cell Antibody) screen ELISA Assay Kit

Insulin Ultrasensitive ELISA Assay Kit

 

Related News:

New Study Utilizing EagleBio’s Human Adiponectin ELISA Assay Kit

New Hormone Discovery: Could it Lead to Ground Breaking Therapy for Type 2 Diabetes?

External Bionic Pancreas Device Brings Hope to Diabetics.

Eagle Biosciences Introduces Anti-Zinc Transporter 8 ELISA

Sensitivity of Islet Cell Antibodies (ICA) ELISA Compared with Indirect Immunofluorescence Assay

New Study Utilizing EagleBio’s  Human Adiponectin ELISA Assay Kit

 

 

EagleBio is pleased to share a recent publication below referencing the use of our Human Adiponectin ELISA Assay Kit. This Adiponectin ELISA Kit  is a quick, simple, and sensitive assay for the quantitative determination of  human adiponectin in human serum and plasma. This assay is a part of our Endocrine Assay Kit Line, a line that offers a comprehensive product grouping of unique and for measuring a variety of analytes for diabetes and obesity research.  

 

Publication Citing EagleBio’s Human Adiponectin ELISA Assay Kit:

Effect of coenzyme Q10 on glycaemic control, oxidative stress and adiponectin in type 2 diabetes

Summary:

This study was planned to investigate the effect of coenzyme Q10 (CoQ10) supplementation on glycaemic control, oxidative stress (OS), and adiponectin levels in type 2 diabetic (T2DM) patients. It is the first study on diabetic patients focused on evaluating the effect of CoQ10 on adiponectin levels.

In conclusion, after eight weeks of supplementation with CoQ10 , it may reduce OS in T2DM patients but it may not change glycaemic control and adiponectin levels. In order to confirm this effect, further investigations with larger populations and longer periods are required.

 

Related Kits:

Human Adiponectin ELISA Assay Kit

Mouse Adiponectin ELISA Assay Kit

Rat Adiponectin ELISA Assay Kit

Resistin ELISA Assay Kit

Endocrine Assay Kits

 

Related News:

Mediagnost Introduces Eagle Biosciences as Distributor in North America

New Hormone Discovery: Could it Lead to Ground Breaking Therapy for Type 2 Diabetes?

Sensitivity of Islet Cell Antibodies (ICA) ELISA Compared with Indirect Immunofluorescence Assay

External Bionic Pancreas Device Brings Hope to Diabetics.

Eagle Biosciences Introduces Anti-Zinc Transporter 8 ELISA

 


Foot infected with septicemic  plague

A teen died recently of the Septicemic plague which is serious illness that occurs when the the bacterium Yersinia pestis enter the bloodstream directly and spreads throughout the body. Yersinia pestis was responsible for killing millions of people in the 1300s in Europe, in a pandemic known as the Black Death.  This bacteria is carried by rodents such as rats, ground squirrels, and prairie dogs (and their fleas) and is prevalent in the western United States. 

The young man of 16 years old who contracted this disease,Taylor Gaes was the first person in Larimer County to get the plague since 1999. There is a an active investigation to determine how he was infected but they believe he may have been bit by infected fleas on his family’s property.  

Unfortunately, the symptoms of the plague can present like the flu, thus they are often misinterpreted which was the case for Taylor. After a few days of being ill, he began coughing up blood and was rushed to the hospital but he died before arriving there. Read More


Routes of Contraction of the Plague:

  • Bite from infected fleas
  • Contact with an infected animal such family pet, rodents, etc.
  • Inhalation of airborne droplets from an infected person or animal (especially cats)
  • Exposure to the bacteria in a laboratory

Symptoms:

Symptoms appear 2 to 6 days after exposure to plague bacteria.

  • Swollen Lymph nodes
  • Headache
  • Fever
  • Chills
  • Fatigue
  • Gastrointestinal Symptoms
  • Extreme Weakness
  • Shock
  • Bleeding into the skin and other organs

Click Here for more signs, symptoms, facts, and prevention tips on the plague.


image above from www.livescience.com

June 2015: Eagle Biosciences, Inc. is pleased to announce a North American
distribution agreement with Mediagnost in Germany. Mediagnost offers a wide
range of top-notch biotechnology services and products which include test
systems for multiple applications. They have a unique focus on the advancement
of Hepatitis A vaccine and the development of endocrine testing methods. Mediagnost’s core research and development projects
encompass the areas of infectious diseases, endocrinology, and neurology.

“I am
thrilled to bring Mediagnost products to EagleBio and add them to our product
offerings.” said Dan Keefe, President of Eagle Biosciences. He continued, “This
certainly is a great opportunity for Eagle as we are establishing a new
strategic partnership with a group of scientific experts that are constantly
driving forward the identification of innovative biomarkers.”

This
product is currently for research use only. Visit the Eagle our website www.EagleBio.com or call 866-411-8023 for full details.

 

Related Kits:

Human Adiponectin ELISA Assay Kit

Mouse Adiponectin ELISA Assay Kit

Rat Adiponectin ELISA Assay Kit

Resistin ELISA Assay Kit

Endocrine Assay Kits

Related News:

New Hormone Discovery: Could it Lead to Ground Breaking Therapy for Type 2 Diabetes?

Sensitivity of Islet Cell Antibodies (ICA) ELISA Compared with Indirect Immunofluorescence Assay

External Bionic Pancreas Device Brings Hope to Diabetics.

Eagle Biosciences Introduces Anti-Zinc Transporter 8 ELISA

New Drug Target to Increase Bone Formation and Treat Multiple Diseases


Recent research at the Scripps Research Institute focused on developing a new drug by investigating a protein known as PPARG (known as the master regulator of fat) and how it can affect the stem cells of the bone marrow.The team of scientists in the Translational Research Institute at Scripps has designed a compound called SR2595 to be used it to repress the PPARG protein. Their studies revealed that by reducing PPARG, they were able to promote bone formation by inducing the formation of osteoblasts (cells that help bone tissue to form).  

PPARG’s close relation to several proteins with known roles in disease provides hope for endless therapeutic opportunities. This is a ground-breaking discovery because this drug target not only could treat and possibly cure numerous bone-related diseases, but it also has enormous potential to treat a variety of other diseases. Read More

Related Kits:

Bone Metabolism Assay Kits

Related News:

EagleBio’s FGF23 (C-terminal) ELISA: Product Highlights

January 2015: Eagle Biosciences Introduces New FGF23(C-Terminal) ELISA Assay

 

30% Discount on our:

 

Total Complement Functional Screen ELISA

Complement Classical Pathway ELISA

Complement Alternative Pathway ELISA

Complement MBL Pathway ELISA

This promotion is good through July 31st, just use code below when ordering.

PROMOTIONAL CODE: COMP0731


Related Products:

Immunology Assay Kits

 

Related News:

EagleBio Spotlight: Complement System